









Markets
/
Stocks
/
nasdaq-gnta
/

Genenta Science SPA

GNTA

View Detailed Chart

3.820USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

69.87MMarket Cap

--P/E TTM



Genenta Science SPA

3.820

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-3.39%

5 Days

+1.06%

1 Month

+0.53%

6 Months

+0.53%

Year to Date

-12.18%

1 Year

-5.21%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

21.000

Target Price

449.74%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Genenta Science SPA

GNTA

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(3)

Buy(5)

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.014

Buy

RSI(14)

52.068

Neutral

STOCH(KDJ)(9,3,3)

49.629

Neutral

ATR(14)

0.158

High Vlolatility

CCI(14)

42.266

Neutral

Williams %R

31.111

Buy

TRIX(12,20)

0.168

Sell

StochRSI(14)

65.226

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

3.818

Buy

MA10

3.792

Buy

MA20

3.828

Sell

MA50

3.813

Buy

MA100

3.892

Sell

MA200

4.265

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.

Ticker SymbolGNTA

CompanyGenenta Science SPA

CEOMr. Pierluigi Paracchi

Websitehttps://www.genenta.com/